GL1X · GenesisL1 explorer

MolNFT v1 · #121872 · protein

Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone G02778174

5I86 · Creb-binding protein: “Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone G02778174”. X-ray diffraction, 2 ligands (69A, SCN), 4 pockets (best druggability 0.62). MolNFT v1 #121872 on GenesisL1: 3D…

PDB
5I86
Type
protein
Length
229 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Creb-binding protein
UniProt
Q92793
Ligands
69A, SCN
Pockets
4 · best druggability 0.62

Structure

x-ray diffraction · 2 distinct chains · 67% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACreb-binding proteinprotein11567% helix, 0% strandQ92793
BCreb-binding proteinprotein11468% helix, 0% strandQ92793

Ligands and binding sites

  • 69A · (4R)-N-benzyl-4-methyl-2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-6-carboxamide · ligand · 2 copies · chains A, B
  • SCN · Thiocyanate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13620.620.7828empty
21020.510.8219EDO, 69A
3840.510.831569A
4610.270.7319empty

Interfaces

1 interface between chains.

  • A–B · 418 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 5I86 · Crystal structure of the bromodomain of human CREBBP bound to the benzodiazepi G02778174 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92793 · AlphaFold monomer V2.0 prediction for creb-binding protein (Q92793) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.